Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients presenting gastrointestinal disorders: A pilot study-Reference-Cited by-同舟云学术

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients presenting gastrointestinal disorders: A pilot study

Published:2006-06-01 Issue:9 Volume:12 Page:1342-1346
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Dumortier Jérôme,Gagnieu Marie-Claude,Salandre Janine,Guillaud Olivier,Guillem Philipe,Adham Mustapha,Boillot Olivier

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.20792/fullpdf

Reference23 articles.

1. A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation;Fisher;Transplantation,1998

2. Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C;Wiesner;Liver Transpl,2005

3. Enteric coating of mycophenolate sodium: a rational approach to limit topical gastrointestinal lesions and extend the therapeutic index of mycophenolate;Bjarnason;Transplant Proc,2001

4. Enteric-coated mycophenolate sodium;Gabardi;Ann Pharmacother,2003

5. Enteric-coated mycophenolate sodium: tolerability profile compared with mycophenolate mofetil;Behrend;Drugs,2005

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-08

2. Lack of concordance between EMIT assay and LC-MS/MS for Therapeutic Drug Monitoring of Mycophenolic Acid: Potential increased risk for graft rejection?;Journal of Pharmaceutical and Biomedical Analysis;2020-08

3. Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?;Drugs in R&D;2018-11-13

4. Circadian variation in intestine toxicity of Mycophenolate mofetil in rats: an experimental and histopathologic study;Biological Rhythm Research;2018-11-02

5. Common issues in the management of patients in the waiting list and after liver transplantation;Digestive and Liver Disease;2017-03